Any 0 3 0 3 O
other 4 9 4 9 O
malignancy 10 20 10 20 B-cancer
that 21 25 21 25 O
required 26 34 26 34 O
active 35 41 35 41 O
chemotherapy 42 54 42 54 B-treatment
within 55 61 55 61 O
the 62 65 62 65 O
previous 66 74 66 74 B-upper_bound
12 75 77 75 77 I-upper_bound
months 78 84 78 84 I-upper_bound
prior 85 90 85 90 I-upper_bound
to 91 93 91 93 O
registration 94 106 94 106 O
and 107 110 107 110 O
the 111 114 111 114 O
disease 115 122 115 122 O
is 123 125 123 125 O
not 126 129 126 129 O
currently 130 139 130 139 O
progressing 140 151 140 151 O
and/or 152 158 152 158 O
metastatic 159 169 159 169 O
. 169 170 169 170 O
The 171 174 171 174 O
exception 175 184 175 184 O
is 185 187 185 187 O
basal 188 193 188 193 B-cancer
cell 194 198 194 198 I-cancer
or 199 201 199 201 O
squamous 202 210 202 210 B-cancer
cell 211 215 211 215 I-cancer
carcinoma 216 225 216 225 I-cancer
of 226 228 226 228 I-cancer
the 229 232 229 232 I-cancer
skin 233 237 233 237 I-cancer
, 237 238 237 238 O
which 239 244 239 244 O
were 245 249 245 249 O
treated 250 257 250 257 O
with 258 262 258 262 O
local 263 268 263 268 O
resection 269 278 269 278 O
only 279 283 279 283 O
or 284 286 284 286 O
carcinoma 287 296 287 296 B-cancer
in 297 299 297 299 I-cancer
situ 300 304 300 304 I-cancer
of 305 307 305 307 I-cancer
the 308 311 308 311 I-cancer
cervix 312 318 312 318 I-cancer

At 0 2 319 321 O
least 3 8 322 327 O
22 9 11 328 330 B-lower_bound
years 12 17 331 336 I-lower_bound
of 18 20 337 339 O
age 21 24 340 343 B-age

Availability 0 12 344 356 O
of 13 15 357 359 O
tissue 16 22 360 366 O
from 23 27 367 371 O
the 28 31 372 375 O
initial 32 39 376 383 O
diagnosis 40 49 384 393 O
and 50 53 394 397 O
the 54 57 398 401 O
recurrent 58 67 402 411 O
tumor 68 73 412 417 B-cancer
that 74 78 418 422 O
is 79 81 423 425 O
estimated 82 91 426 435 O
to 92 94 436 438 O
be 95 97 439 441 O
of 98 100 442 444 O
sufficient 101 111 445 455 O
quality 112 119 456 463 O
and 120 123 464 467 O
quantity 124 132 468 476 O
for 133 136 477 480 O
both 137 141 481 485 O
genomic 142 149 486 493 O
DNA 150 153 494 497 B-clinical_variable
and 154 157 498 501 O
total 158 163 502 507 O
RNA 164 167 508 511 B-clinical_variable
isolation 168 177 512 521 I-clinical_variable
; 177 178 521 522 O
preferably 179 189 523 533 O
some 190 194 534 538 O
of 195 197 539 541 O
the 198 201 542 545 O
tissue 202 208 546 552 O
would 209 214 553 558 O
be 215 217 559 561 O
snap 218 222 562 566 O
frozen 223 229 567 573 O
for 230 233 574 577 O
high 234 238 578 582 O
quality 239 246 583 590 O
RNA 247 250 591 594 O
preparation 251 262 595 606 O

Because 0 7 607 614 O
the 8 11 615 618 O
genetic 12 19 619 626 O
analyses 20 28 627 635 O
described 29 38 636 645 O
in 39 41 646 648 O
Section 42 49 649 656 O
8.0 50 53 657 660 O
will 54 58 661 665 O
be 59 61 666 668 O
performed 62 71 669 678 O
under 72 77 679 684 O
HRPO 78 82 685 689 O
# 82 83 689 690 O
201111001 84 93 691 700 O
( 94 95 701 702 O
Analysis 95 103 702 710 O
of 104 106 711 713 O
Histological 107 119 714 726 O
, 119 120 726 727 O
Genomic 121 128 728 735 O
, 128 129 735 736 O
Molecular 130 139 737 746 O
, 139 140 746 747 O
and 141 144 748 751 O
Clinical 145 153 752 760 O
Factors 154 161 761 768 O
in 162 164 769 771 O
CNS 165 168 772 775 B-cancer
Cancer 169 175 776 782 I-cancer
: 175 176 782 783 O
the 177 180 784 787 O
Neuro 181 186 788 793 O
- 186 187 793 794 O
Oncology 187 195 794 802 O
Group 196 201 803 808 O
) 201 202 808 809 O
, 202 203 809 810 O
for 204 207 811 814 O
patients 208 216 815 823 O
enrolling 217 226 824 833 O
in 227 229 834 836 O
this 230 234 837 841 O
trial 235 240 842 847 O
at 241 243 848 850 O
WUSM 244 248 851 855 O
, 248 249 855 856 O
it 250 252 857 859 O
is 253 255 860 862 O
required 256 264 863 871 O
that 265 269 872 876 O
WUSM 270 274 877 881 O
patients 275 283 882 890 O
must 284 288 891 895 O
also 289 293 896 900 O
enroll 294 300 901 907 O
in 301 303 908 910 O
HRPO 304 308 911 915 O
# 308 309 915 916 O
201111001 310 319 917 926 O
. 319 320 926 927 O
The 321 324 928 931 O
genetic 325 332 932 939 O
analyses 333 341 940 948 O
for 342 345 949 952 O
UF 346 348 953 955 O
patients 349 357 956 964 O
will 358 362 965 969 O
take 363 367 970 974 O
place 368 373 975 980 O
at 374 376 981 983 O
WUSM 377 381 984 988 O
under 382 387 989 994 O
the 388 391 995 998 O
auspices 392 400 999 1007 O
of 401 403 1008 1010 O
this 404 408 1011 1015 O
protocol 409 417 1016 1024 O

Bevacizumab 0 11 1025 1036 B-treatment
- 11 12 1036 1037 O
na√Øve 12 17 1037 1042 O
patients 18 26 1043 1051 O
: 26 27 1051 1052 O
These 28 33 1053 1058 O
patients 34 42 1059 1067 O
may 43 46 1068 1071 O
not 47 50 1072 1075 O
have 51 55 1076 1080 O
more 56 60 1081 1085 O
than 61 65 1086 1090 O
one 66 69 1091 1094 B-lower_bound
prior 70 75 1095 1100 O
relapse 76 83 1101 1108 O
not 84 87 1109 1112 O
counting 88 96 1113 1121 O
the 97 100 1122 1125 O
current 101 108 1126 1133 O
relapse 109 116 1134 1141 O
being 117 122 1142 1147 O
treated 123 130 1148 1155 O
by 131 133 1156 1158 O
this 134 138 1159 1163 O
protocol 139 147 1164 1172 O
and 148 151 1173 1176 O
must 152 156 1177 1181 O
have 157 161 1182 1186 O
received 162 170 1187 1195 O
at 171 173 1196 1198 O
least 174 179 1199 1204 O
one 180 183 1205 1208 O
prior 184 189 1209 1214 B-treatment
chemotherapy 190 202 1215 1227 I-treatment
regimen 203 210 1228 1235 I-treatment
, 210 211 1235 1236 O
which 212 217 1237 1242 O
must 218 222 1243 1247 O
have 223 227 1248 1252 O
included 228 236 1253 1261 O
temozolomide 237 249 1262 1274 B-treatment

Bevacizumab 0 11 1275 1286 B-treatment
- 11 12 1286 1287 O
refractory 12 22 1287 1297 O
patients 23 31 1298 1306 O
: 31 32 1306 1307 O
These 33 38 1308 1313 O
patients 39 47 1314 1322 O
may 48 51 1323 1326 O
not 52 55 1327 1330 O
have 56 60 1331 1335 O
more 61 65 1336 1340 O
than 66 70 1341 1345 O
2 71 72 1346 1347 B-lower_bound
prior 73 78 1348 1353 I-lower_bound
relapses 79 87 1354 1362 O
not 88 91 1363 1366 O
counting 92 100 1367 1375 O
the 101 104 1376 1379 O
current 105 112 1380 1387 O
relapse 113 120 1388 1395 O
being 121 126 1396 1401 O
treated 127 134 1402 1409 O
by 135 137 1410 1412 O
this 138 142 1413 1417 O
protocol 143 151 1418 1426 O
and 152 155 1427 1430 O
must 156 160 1431 1435 O
have 161 165 1436 1440 O
received 166 174 1441 1449 O
multiple 175 183 1450 1458 O
chemotherapy 184 196 1459 1471 B-treatment
regimens 197 205 1472 1480 O
, 205 206 1480 1481 O
including 207 216 1482 1491 O
a 217 218 1492 1493 O
temozolomide 219 231 1494 1506 B-treatment
regimen 232 239 1507 1514 O
and 240 243 1515 1518 O
a 244 245 1519 1520 O
bevacizumab 246 257 1521 1532 B-treatment
regimen 258 265 1533 1540 O

Currently 0 9 1541 1550 O
receiving 10 19 1551 1560 O
any 20 23 1561 1564 O
other 24 29 1565 1570 O
investigational 30 45 1571 1586 B-treatment
agents 46 52 1587 1593 I-treatment
that 53 57 1594 1598 O
are 58 61 1599 1602 O
intended 62 70 1603 1611 O
as 71 73 1612 1614 O
treatments 74 84 1615 1625 B-treatment
of 85 87 1626 1628 O
recurrent 88 97 1629 1638 O
GBM 98 101 1639 1642 B-cancer

Histologically 0 14 1643 1657 O
confirmed 15 24 1658 1667 O
GBM 25 28 1668 1671 B-cancer
( 29 30 1672 1673 I-cancer
WHO 30 33 1673 1676 I-cancer
grade 34 39 1677 1682 I-cancer
IV 40 42 1683 1685 I-cancer
) 42 43 1685 1686 I-cancer
; 43 44 1686 1687 O
rare 45 49 1688 1692 O
GBM 50 53 1693 1696 O
variants 54 62 1697 1705 O
( 63 64 1706 1707 O
e.g. 64 68 1707 1711 O
gliosarcoma 69 80 1712 1723 B-cancer
, 80 81 1723 1724 O
giant 82 87 1725 1730 B-cancer
cell 88 92 1731 1735 I-cancer
GBM 93 96 1736 1739 I-cancer
, 96 97 1739 1740 O
small 98 103 1741 1746 B-cancer
cell 104 108 1747 1751 I-cancer
GBM 109 112 1752 1755 I-cancer
, 112 113 1755 1756 O
GBM 114 117 1757 1760 B-cancer
with 118 122 1761 1765 I-cancer
oligodendroglioma 123 140 1766 1783 I-cancer
features 141 149 1784 1792 O
, 149 150 1792 1793 O
GBM 151 154 1794 1797 B-cancer
with 155 159 1798 1802 I-cancer
PNET 160 164 1803 1807 I-cancer
features 165 173 1808 1816 O
) 173 174 1816 1817 O
are 175 178 1818 1821 O
allowed 179 186 1822 1829 O
. 186 187 1829 1830 O
Patients 188 196 1831 1839 O
will 197 201 1840 1844 O
be 202 204 1845 1847 O
eligible 205 213 1848 1856 O
if 214 216 1857 1859 O
the 217 220 1860 1863 O
original 221 229 1864 1872 O
histology 230 239 1873 1882 O
was 240 243 1883 1886 O
low 244 247 1887 1890 B-cancer
- 247 248 1890 1891 I-cancer
grade 248 253 1891 1896 I-cancer
glioma 254 260 1897 1903 I-cancer
and 261 264 1904 1907 O
a 265 266 1908 1909 O
subsequent 267 277 1910 1920 O
histological 278 290 1921 1933 O
diagnosis 291 300 1934 1943 O
of 301 303 1944 1946 O
GBM 304 307 1947 1950 O
is 308 310 1951 1953 O
made 311 315 1954 1958 O

History 0 7 1959 1966 O
of 8 10 1967 1969 O
hypersensitivity 11 27 1970 1986 O
to 28 30 1987 1989 O
hydrogel 31 39 1990 1998 B-clinical_variable

Implanted 0 9 1999 2008 B-treatment
pacemaker 10 19 2009 2018 I-treatment
, 19 20 2018 2019 O
programmable 21 33 2020 2032 B-treatment
shunts 34 40 2033 2039 I-treatment
, 40 41 2039 2040 O
defibrillator 42 55 2041 2054 B-treatment
, 55 56 2054 2055 O
deep 57 61 2056 2060 B-treatment
brain 62 67 2061 2066 I-treatment
stimulator 68 78 2067 2077 I-treatment
, 78 79 2077 2078 O
vagus 80 85 2079 2084 B-treatment
nerve 86 91 2085 2090 I-treatment
stimulator 92 102 2091 2101 I-treatment
, 102 103 2101 2102 O
and 104 107 2103 2106 O
other 108 113 2107 2112 B-treatment
implanted 114 123 2113 2122 I-treatment
electronic 124 134 2123 2133 I-treatment
devices 135 142 2134 2141 I-treatment
in 143 145 2142 2144 I-treatment
the 146 149 2145 2148 I-treatment
brain 150 155 2149 2154 I-treatment
or 156 158 2155 2157 I-treatment
the 159 162 2158 2161 I-treatment
spinal 163 169 2162 2168 I-treatment
cord 170 174 2169 2173 I-treatment

Infra 0 5 2174 2179 B-cancer
- 5 6 2179 2180 I-cancer
tentorial 6 15 2180 2189 I-cancer
tumor 16 21 2190 2195 I-cancer

Karnofsky 0 9 2196 2205 B-clinical_variable
performance 10 21 2206 2217 I-clinical_variable
status 22 28 2218 2224 I-clinical_variable
of 29 31 2225 2227 O
at 32 34 2228 2230 O
least 35 40 2231 2236 O
60 41 43 2237 2239 B-lower_bound
% 43 44 2239 2240 I-lower_bound

Life 0 4 2241 2245 B-clinical_variable
expectancy 5 15 2246 2256 I-clinical_variable
of 16 18 2257 2259 O
at 19 21 2260 2262 O
least 22 27 2263 2268 O
3 28 29 2269 2270 B-lower_bound
months 30 36 2271 2277 I-lower_bound

Participants 0 12 2278 2290 O
of 13 15 2291 2293 O
childbearing 16 28 2294 2306 O
age 29 32 2307 2310 B-age
must 33 37 2311 2315 O
use 38 41 2316 2319 B-contraception_consent
effective 42 51 2320 2329 I-contraception_consent
contraception 52 65 2330 2343 I-contraception_consent

Patients 0 8 2344 2352 O
must 9 13 2353 2357 O
agree 14 19 2358 2363 O
to 20 22 2364 2366 O
forgo 23 28 2367 2372 O
any 29 32 2373 2376 O
other 33 38 2377 2382 O
treatments 39 49 2383 2393 B-treatment
, 49 50 2393 2394 O
including 51 60 2395 2404 O
but 61 64 2405 2408 O
not 65 68 2409 2412 O
limited 69 76 2413 2420 O
to 77 79 2421 2423 O
cytotoxic 80 89 2424 2433 B-treatment
or 90 92 2434 2436 O
biologic 93 101 2437 2445 B-treatment
chemotherapies 102 116 2446 2460 I-treatment
, 116 117 2460 2461 O
that 118 122 2462 2466 O
are 123 126 2467 2470 O
intended 127 135 2471 2479 O
to 136 138 2480 2482 O
treat 139 144 2483 2488 O
the 145 148 2489 2492 O
recurrent 149 158 2493 2502 O
GBM 159 162 2503 2506 B-cancer
while 163 168 2507 2512 O
receiving 169 178 2513 2522 O
treatment 179 188 2523 2532 O
with 189 193 2533 2537 O
NovoTTF 194 201 2538 2545 B-treatment
Therapy 202 209 2546 2553 I-treatment

Planned 0 7 2554 2561 O
biopsy 8 14 2562 2568 B-treatment
or 15 17 2569 2571 O
resection 18 27 2572 2581 B-treatment
of 28 30 2582 2584 O
recurrent 31 40 2585 2594 O
tumor 41 46 2595 2600 B-cancer
for 47 50 2601 2604 O
therapeutic 51 62 2605 2616 O
and/or 63 69 2617 2623 O
diagnostic 70 80 2624 2634 O
purpose 81 88 2635 2642 O
, 88 89 2642 2643 O
and 90 93 2644 2647 O
with 94 98 2648 2652 O
adequate 99 107 2653 2661 O
bone 108 112 2662 2666 O
marrow 113 119 2667 2673 O
, 119 120 2673 2674 O
hepatic 121 128 2675 2682 O
, 128 129 2682 2683 O
cardiac 130 137 2684 2691 O
, 137 138 2691 2692 O
and 139 142 2693 2696 O
renal 143 148 2697 2702 O
function 149 157 2703 2711 O
to 158 160 2712 2714 O
undergo 161 168 2715 2722 O
this 169 173 2723 2727 O
planned 174 181 2728 2735 B-treatment
procedure 182 191 2736 2745 I-treatment

Pregnant 0 8 2746 2754 B-pregnancy

Received 0 8 2755 2763 O
radiotherapy 9 21 2764 2776 B-treatment
of 22 24 2777 2779 O
at 25 27 2780 2782 O
least 28 33 2783 2788 O
45 34 36 2789 2791 B-lower_bound
Gy 37 39 2792 2794 B-treatment
and 40 43 2795 2798 O
temozolomide 44 56 2799 2811 B-treatment
chemotherapy 57 69 2812 2824 I-treatment
as 70 72 2825 2827 O
initial 73 80 2828 2835 O
treatment 81 90 2836 2845 B-treatment
for 91 94 2846 2849 O
GBM 95 98 2850 2853 O

Recovery 0 8 2854 2862 O
from 9 13 2863 2867 O
the 14 17 2868 2871 O
toxic 18 23 2872 2877 O
effects 24 31 2878 2885 O
of 32 34 2886 2888 O
prior 35 40 2889 2894 B-treatment
therapy 41 48 2895 2902 I-treatment
to 49 51 2903 2905 O
not 52 55 2906 2909 O
more 56 60 2910 2914 O
than 61 65 2915 2919 O
grade 66 71 2920 2925 B-lower_bound
1 72 73 2926 2927 I-lower_bound
or 74 76 2928 2930 O
> 77 78 2931 2932 O
3 78 79 2932 2933 B-lower_bound
weeks 80 85 2934 2939 I-lower_bound
from 86 90 2940 2944 O
prior 91 96 2945 2950 O
therapy 97 104 2951 2958 O
to 105 107 2959 2961 O
registration 108 120 2962 2974 O
, 120 121 2974 2975 O
whichever 122 131 2976 2985 O
is 132 134 2986 2988 O
later 135 140 2989 2994 O

There 0 5 2995 3000 O
must 6 10 3001 3005 O
be 11 13 3006 3008 O
an 14 16 3009 3011 O
interval 17 25 3012 3020 O
of 26 28 3021 3023 O
at 29 31 3024 3026 O
least 32 37 3027 3032 O
12 38 40 3033 3035 O
weeks 41 46 3036 3041 O
from 47 51 3042 3046 O
the 52 55 3047 3050 O
completion 56 66 3051 3061 O
of 67 69 3062 3064 O
radiotherapy 70 82 3065 3077 B-treatment
to 83 85 3078 3080 O
start 86 91 3081 3086 O
of 92 94 3087 3089 O
device 95 101 3090 3096 O
treatment 102 111 3097 3106 O
. 111 112 3106 3107 O
When 113 117 3108 3112 O
the 118 121 3113 3116 O
interval 122 130 3117 3125 O
is 131 133 3126 3128 O
less 134 138 3129 3133 O
than 139 143 3134 3138 O
12 144 146 3139 3141 O
weeks 147 152 3142 3147 O
from 153 157 3148 3152 O
the 158 161 3153 3156 O
completion 162 172 3157 3167 O
of 173 175 3168 3170 O
radiotherapy 176 188 3171 3183 O
, 188 189 3183 3184 O
the 190 193 3185 3188 O
histological 194 206 3189 3201 O
confirmation 207 219 3202 3214 O
of 220 222 3215 3217 O
progression 223 234 3218 3229 O
must 235 239 3230 3234 O
be 240 242 3235 3237 O
unequivocal 243 254 3238 3249 O
per 255 258 3250 3253 O
RANO 259 263 3254 3258 O
criteria 264 272 3259 3267 O
. 272 273 3267 3268 O
The 274 277 3269 3272 O
use 278 281 3273 3276 O
of 282 284 3277 3279 O
PET 285 288 3280 3283 B-treatment
scan 289 293 3284 3288 I-treatment
, 293 294 3288 3289 O
perfusion 295 304 3290 3299 B-treatment
imaging 305 312 3300 3307 I-treatment
, 312 313 3307 3308 O
and 314 317 3309 3312 O
MRspectroscopy 318 332 3313 3327 B-treatment
to 333 335 3328 3330 O
differentiate 336 349 3331 3344 O
between 350 357 3345 3352 O
true 358 362 3353 3357 O
early 363 368 3358 3363 O
progression 369 380 3364 3375 O
and 381 384 3376 3379 O
pseudoprogression 385 402 3380 3397 O
prior 403 408 3398 3403 B-treatment
to 409 411 3404 3406 I-treatment
biopsy 412 418 3407 3413 I-treatment
or 419 421 3414 3416 O
resection 422 431 3417 3426 O
of 432 434 3427 3429 O
probable 435 443 3430 3438 O
recurrent 444 453 3439 3448 O
tumor 454 459 3449 3454 B-cancer
is 460 462 3455 3457 O
per 463 466 3458 3461 O
standard 467 475 3462 3470 O
of 476 478 3471 3473 O
care 479 483 3474 3478 O

Unable 0 6 3479 3485 O
to 7 9 3486 3488 O
undergo 10 17 3489 3496 O
brain 18 23 3497 3502 O
MRI 24 27 3503 3506 B-treatment
due 28 31 3507 3510 O
to 32 34 3511 3513 O
medical 35 42 3514 3521 O
or 43 45 3522 3524 O
personal 46 54 3525 3533 O
reasons 55 62 3534 3541 O

Uncontrolled 0 12 3542 3554 O
intercurrent 13 25 3555 3567 O
illness 26 33 3568 3575 O
including 34 43 3576 3585 O
, 43 44 3585 3586 O
but 45 48 3587 3590 O
not 49 52 3591 3594 O
limited 53 60 3595 3602 O
to 61 63 3603 3605 O
, 63 64 3605 3606 O
ongoing 65 72 3607 3614 O
or 73 75 3615 3617 O
active 76 82 3618 3624 B-chronic_disease
infection 83 92 3625 3634 I-chronic_disease
, 92 93 3634 3635 O
symptomatic 94 105 3636 3647 O
congestive 106 116 3648 3658 B-chronic_disease
heart 117 122 3659 3664 I-chronic_disease
failure 123 130 3665 3672 I-chronic_disease
, 130 131 3672 3673 O
unstable 132 140 3674 3682 B-chronic_disease
angina 141 147 3683 3689 I-chronic_disease
pectoris 148 156 3690 3698 I-chronic_disease
, 156 157 3698 3699 O
cardiac 158 165 3700 3707 B-chronic_disease
arrhythmia 166 176 3708 3718 I-chronic_disease
, 176 177 3718 3719 O
recent 178 184 3720 3726 O
heart 185 190 3727 3732 B-chronic_disease
attack 191 197 3733 3739 I-chronic_disease
within 198 204 3740 3746 O
the 205 208 3747 3750 O
previous 209 217 3751 3759 B-upper_bound
12 218 220 3760 3762 I-upper_bound
months 221 227 3763 3769 I-upper_bound
or 228 230 3770 3772 O
severe 231 237 3773 3779 O
heart 238 243 3780 3785 O
problems 244 252 3786 3794 O
, 252 253 3794 3795 O
or 254 256 3796 3798 O
psychiatric 257 268 3799 3810 B-chronic_disease
illness 269 276 3811 3818 I-chronic_disease
/ 276 277 3818 3819 I-chronic_disease
social 277 283 3819 3825 I-chronic_disease
situations 284 294 3826 3836 I-chronic_disease
that 295 299 3837 3841 O
would 300 305 3842 3847 O
limit 306 311 3848 3853 O
compliance 312 322 3854 3864 O
with 323 327 3865 3869 O
study 328 333 3870 3875 O
requirements 334 346 3876 3888 O

Unequivocal 0 11 3889 3900 O
evidence 12 20 3901 3909 O
of 21 23 3910 3912 O
recurrent 24 33 3913 3922 O
or 34 36 3923 3925 O
progressive 37 48 3926 3937 O
GBM 49 52 3938 3941 B-cancer
before 53 59 3942 3948 O
or 60 62 3949 3951 O
after 63 68 3952 3957 O
bevacizumab 69 80 3958 3969 B-treatment
treatment 81 90 3970 3979 I-treatment
first 91 96 3980 3985 O
based 97 102 3986 3991 O
on 103 105 3992 3994 O
radiographic 106 118 3995 4007 O
appearances 119 130 4008 4019 O
then 131 135 4020 4024 O
confirmed 136 145 4025 4034 O
by 146 148 4035 4037 O
histologic 149 159 4038 4048 O
confirmation 160 172 4049 4061 O
through 173 180 4062 4069 O
biopsy 181 187 4070 4076 B-treatment
or 188 190 4077 4079 O
resection 191 200 4080 4089 B-treatment

